Grant S Schulert1, Paul D Hain2, Derek J Williams3. 1. Department of Pediatrics, Vanderbilt University School of Medicine and the Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee; and grant.schulert@cchmc.org. 2. University of Texas Southwestern Medical Center and Children's Medical Center, Dallas, Texas. 3. Department of Pediatrics, Vanderbilt University School of Medicine and the Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee; and.
Abstract
OBJECTIVE: To examine whether results of a polymerase chain reaction-based respiratory viral panel (RVP) are associated with changes in antibiotic use or differential clinical outcomes among children hospitalized with pneumonia. METHODS: We retrospectively identified otherwise healthy children hospitalized over a 3-year period at a single institution with community-acquired pneumonia who had an RVP performed within 24 hours of admission. We examined associations between RVP results and clinical outcomes as well as management decisions including initiation and duration of intravenous antibiotics. RESULTS: Among 202 children, a positive RVP (n = 127, 63%) was associated with a more complicated clinical course, although this was due largely to more severe disease seen in younger children and those with respiratory syncytial virus (n = 38, 30% of positive detections). Detection of a virus did not influence antibiotic therapy. Included children were younger and had more severe illness than children hospitalized with pneumonia at the same institution without an RVP obtained. CONCLUSIONS: In our study, only respiratory syncytial virus was associated with a more severe clinical course compared with RVP-negative children. Regardless of the virus detected, RVP positivity did not influence antibiotic usage. However, RVP use focused primarily on children with severe pneumonia. Whether similar testing influences management decisions among children with less severe illness deserves further study.
OBJECTIVE: To examine whether results of a polymerase chain reaction-based respiratory viral panel (RVP) are associated with changes in antibiotic use or differential clinical outcomes among children hospitalized with pneumonia. METHODS: We retrospectively identified otherwise healthy children hospitalized over a 3-year period at a single institution with community-acquired pneumonia who had an RVP performed within 24 hours of admission. We examined associations between RVP results and clinical outcomes as well as management decisions including initiation and duration of intravenous antibiotics. RESULTS: Among 202 children, a positive RVP (n = 127, 63%) was associated with a more complicated clinical course, although this was due largely to more severe disease seen in younger children and those with respiratory syncytial virus (n = 38, 30% of positive detections). Detection of a virus did not influence antibiotic therapy. Included children were younger and had more severe illness than children hospitalized with pneumonia at the same institution without an RVP obtained. CONCLUSIONS: In our study, only respiratory syncytial virus was associated with a more severe clinical course compared with RVP-negative children. Regardless of the virus detected, RVP positivity did not influence antibiotic usage. However, RVP use focused primarily on children with severe pneumonia. Whether similar testing influences management decisions among children with less severe illness deserves further study.
Authors: Grant S Schulert; Zengqi Lu; Tammy Wingo; Yi-Wei Tang; Benjamin R Saville; Paul D Hain Journal: Pediatr Infect Dis J Date: 2013-05 Impact factor: 2.129
Authors: T Juvén; J Mertsola; M Waris; M Leinonen; O Meurman; M Roivainen; J Eskola; P Saikku; O Ruuskanen Journal: Pediatr Infect Dis J Date: 2000-04 Impact factor: 2.129
Authors: N Esther Babady; Peter Mead; Jeffrey Stiles; Carrie Brennan; Haijing Li; Susan Shuptar; Charles W Stratton; Yi-Wei Tang; Mini Kamboj Journal: J Clin Microbiol Date: 2012-04-18 Impact factor: 5.948
Authors: Ian C Michelow; Kurt Olsen; Juanita Lozano; Nancy K Rollins; Lynn B Duffy; Thedi Ziegler; Jaana Kauppila; Maija Leinonen; George H McCracken Journal: Pediatrics Date: 2004-04 Impact factor: 7.124
Authors: Jan Jelrik Oosterheert; Anton M van Loon; Rob Schuurman; Andy I M Hoepelman; Eelko Hak; Steven Thijsen; George Nossent; Margriet M E Schneider; Willem M N Hustinx; Marc J M Bonten Journal: Clin Infect Dis Date: 2005-10-13 Impact factor: 9.079
Authors: Alma C van de Pol; Tom F W Wolfs; Carline E A Tacke; Cuno S P Uiterwaal; Johannes Forster; Anton M van Loon; Jan L L Kimpen; John W A Rossen; Nicolaas J G Jansen Journal: Pediatr Pulmonol Date: 2010-12-30
Authors: Matthew S Kelly; Marek Smieja; Kathy Luinstra; Kathleen E Wirth; David M Goldfarb; Andrew P Steenhoff; Tonya Arscott-Mills; Coleen K Cunningham; Sefelani Boiditswe; Warona Sethomo; Samir S Shah; Rodney Finalle; Kristen A Feemster Journal: PLoS One Date: 2015-05-14 Impact factor: 3.240